Zirconia-based composite customized healing abutments for healthier soft tissue around dental implants
Official title: Peri-implant Soft Tissue Response to Direct Zirconia-Based Composite Customized Healing Abutment: A Randomized Controlled Clinical Study With Biochemical Analysis
Run by Ain Shams University · NCT07095881 · Data updated 2026-11-12
This test will compare zirconia-based composite customized healing abutments with conventional composite abutments to see if they help gum tissue heal better after delayed dental implant placement in adults missing a tooth.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 50 Years |
| Sex | All |
| Enrollment | 22 (estimated) |
| Sponsor | Ain Shams University Academic / other |
| Locations | 1 site (Cairo, Abaseya) |
| Status | Recruiting |
| Started | January 6, 2025 |
| Main results expected | June 2026 |
| Study ends | December 2026 |
| Registry record updated | July 31, 2025 |
| Trial ID | NCT07095881 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 20–50 years old who are systemically healthy, non-smokers with good oral hygiene, have a missing tooth suitable for a standard implant without augmentation, primary implant stability (ISQ ≥70), at least six natural teeth in the same arch, and a thick soft-tissue phenotype.
✕Probably not a fit
Patients who smoke, have poor oral hygiene, require bone or soft-tissue augmentation, are pregnant or lactating, belong to vulnerable groups, or have a thin soft-tissue phenotype are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults needing delayed dental implants will receive either a direct zirconia-based composite customized healing abutment or a conventional composite customized healing abutment placed at the time of implant placement and will be followed for three months. Clinical outcomes include pink esthetic score and papilla index measured at baseline and at 1, 2 and 3 months, while peri-implant sulcus fluid will be sampled with Periopaper to measure IL-1β at two months as a biochemical inflammation marker. The trial enrolls systemically healthy adults aged 20–50 with adequate implant primary stability (ISQ ≥70), a thick soft-tissue phenotype, and no need for bone or soft-tissue augmentation, excluding smokers, pregnant or lactating women, and vulnerable groups. All procedures and follow-up visits are performed at the Faculty of Dentistry, Ain Shams University in Cairo.
Why it matters
Potential benefit: If successful, these zirconia-based composite abutments could reduce local inflammation and improve soft-tissue healing and esthetic outcomes around dental implants.
How similar studies have gone: Laboratory and some clinical studies indicate zirconia surfaces can be more biocompatible and provoke less inflammation, but the specific use of direct zirconia-based composite customized healing abutments is relatively novel and not yet widely validated clinically.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients should be systematically free from any disease as according to Cornell Medical Index-Health Questionnaire (Pendleton et al., 2004). 2. Both genders. 3. Age from 20-50 years. 4. Missing tooth to be restored with standard implant, with no need for additional bone and soft tissue augmentation procedures (Beretta et al., 2019). 5. Implants primary stability ISQ ≥ 70 unites using the Osstell Mentor (Baltayan et al., 2016). 6. Sound Mesial and distal neighboring teeth. 7. At least 6 natural teeth remaining in the same arch . 8. Mouth opening ≥ 30mm. 9. Thick phenotype. Exclusion Criteria: 1. Poor oral hygiene condition. 2. Pregnant and lactating females. 3. Smokers. 4. Vulnerable groups (Prisoners and handicaps).
Where it's running
-
Faculty of Dentistry Ain Shams University
Cairo, Abaseya, Egypt Recruiting
Study contacts
- Study coordinator: Ahmed A El Sayed, MSc Perio
- Email: ahmed.abdelmoteleb.std@dent.asu.edu.eg
- Phone: +201127999187
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NAVA use in preterm neonates with respiratory distress syndrome
This trial tests whether neurally adjusted ventilatory assist (NAVA) helps preterm babies with respiratory distress syndrome breathe more easily than conventional ventilation.
-
Ruta C and Vitamin C in Sepsis: Adding antioxidants to standard care
This trial tests whether adding Ruta C (rutin plus vitamin C) or vitamin C alone to standard sepsis treatment helps adults in the ICU stay shorter and recover better.
-
Left DLPFC rTMS vs iTBS for emotional dysregulation, impulsivity, and NSSI in Borderline Personality Disorder
This trial tests whether high-frequency rTMS or intermittent theta-burst stimulation over the left DLPFC can help reduce emotional instability, impulsivity, and non-suicidal self-injury in adults with Borderline Personality Disorder.
-
Trimetazidine as an extra therapy for aluminum phosphide poisoning
In this pilot trial, adults with acute aluminum phosphide poisoning receive standard care plus trimetazidine to see if it helps save lives and improve recovery.
-
Comparing 3D Face Scans with Manual Measurements for Vertical Dimension in People with Complete Dentures
This study tests whether a 3D face scan can reliably measure the vertical dimension of occlusion in people who wear complete dentures, compared with traditional manual methods.
-
Pre-adapted 3D-printed, patient-specific mesh for unilateral orbital fractures with or without navigation
This study tests whether pre-bending an in-stock titanium mesh using a patient’s 3D-printed skull model improves repair outcomes for unilateral orbital fractures compared with conventional free-hand bending and with navigation-assisted placement.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.